AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
Log in

NASDAQ:ARRYArray Biopharma Earnings Date, Estimates & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$47.85
MA: $47.85
$47.85
52-Week Range N/A
Volume206,508 shs
Average Volume4.99 million shs
Market Capitalization$10.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Earnings

Array Biopharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Array Biopharma (NASDAQ:ARRY) Earnings Estimates

2020 EPS Consensus Estimate: ($0.46)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.21)($0.21)($0.21)
Q2 20201($0.21)($0.21)($0.21)
Q3 20202($0.14)$0.06($0.04)
Q4 20202($0.12)$0.13$0.01

Array Biopharma (NASDAQ ARRY) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/7/20193/31/2019($0.21)($0.17)($0.17)$54.04 million$64.68 millionListen
2/5/201912/31/2018($0.16)($0.05)($0.05)$52.44 million$82.55 millionListen
10/30/20189/30/2018($0.22)($0.12)($0.12)$34.47 million$56.91 millionListen
8/14/2018Q4 2018($0.24)($0.25)($0.23)$38.73 million$35.40 millionN/A
5/9/2018Q3 2018($0.22)($0.11)($0.11)$28.81 million$66.37 millionN/A
2/6/2018Q2 2018($0.23)($0.17)($0.17)$26.81 million$42.21 millionN/A
10/31/2017Q1 2018($0.22)($0.22)($0.22)$33.74 million$29.75 millionN/A
8/9/2017Q4 2017($0.21)($0.17)($0.17)$28.64 million$33.80 millionListen
5/10/2017Q3 2017($0.1610)($0.21)($0.21)$38.28 million$33.28 millionN/A
2/9/2017Q2 2017($0.18)($0.14)($0.14)$31.90 million$44.50 millionListen
11/1/2016Q117($0.16)($0.20)($0.20)$32.47 million$39.30 millionListen
8/4/2016Q416($0.14)($0.17)($0.17)$41.51 million$43.20 millionListen
5/3/2016Q316($0.12)($0.16)($0.16)$30.35 million$43.00 millionListen
2/2/2016Q216($0.06)($0.17)($0.17)$32.70 million$35.40 millionListen
11/4/2015Q116($0.18)($0.15)($0.15)$14.02 million$16.20 millionListen
8/3/2015Q415($0.16)($0.09)($0.11)$10.29 million$12.30 millionListen
5/4/2015Q315($0.01)$0.37($0.59)$6.00 million$6.60 millionListen
2/3/2015Q215($0.20)($0.06)($0.06)$10.20 million$26.92 millionListen
11/4/2014Q115($0.22)($0.21)($0.21)$6.35 million$6.07 millionListen
8/12/2014Q414($0.23)($0.22)($0.22)$8.10 million$6.00 millionListen
4/29/2014Q314($0.21)($0.20)($0.20)$9.40 million$7.80 millionListen
2/4/2014Q2 2014($0.17)($0.13)($0.13)$13.49 million$14.10 millionListen
10/31/2013Q1 2014($0.18)($0.13)($0.13)$11.20 million$14.20 millionListen
8/7/2013Q4 2013($0.13)($0.06)$0.03$16.13 million$25.40 millionListen
5/6/2013Q3 2013($0.15)($0.19)($0.19)$14.54 million$10.00 millionListen
2/4/2013Q2 2013($0.14)($0.10)$16.52 million$18.40 millionListen
10/29/2012Q113($0.15)($0.13)$16.70 million$15.80 millionN/A
8/13/2012($0.11)($0.09)N/A
4/30/2012($0.16)($0.11)Listen
1/30/2012($0.12)($0.06)N/A
10/31/2011Q1 2012($0.19)($0.06)($0.06)N/A
8/8/2011Q4 2011($0.27)($0.17)$0.04N/A
5/2/2011($0.25)($0.20)N/A
1/31/2011($0.28)($0.23)N/A
11/8/2010Q1 2011($0.28)($0.20)($0.20)N/A
8/9/2010Q4 2010($0.32)($0.30)($0.30)N/A
5/3/2010Q3 2010($0.34)($0.30)($0.30)N/A
2/1/2010Q2 2010($0.55)($0.44)($0.44)N/A
11/2/2009Q1 2010($0.55)($0.52)($0.52)N/A
8/10/2009Q4 2009($0.55)($0.55)($0.55)N/A
5/4/2009Q3 2009($0.58)($0.55)($0.48)N/A
2/2/2009Q2 2009($0.65)($0.57)($0.35)N/A
11/3/2008Q1 2009($0.65)($0.63)($0.55)N/A
8/11/2008Q4 2008($0.63)($0.68)($0.68)N/A
5/5/2008Q3 2008($0.51)($0.51)($0.51)N/A
2/4/2008Q2 2008($0.46)($0.43)($0.43)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.